Blautix (4d pharma)

N/A

Report date: 2025/05/15 20:00:08

Base Information

Drug NameBlautix (4d pharma)
Drug Alias NameBlautixMRx-1234CJRB-205
ClassificationBiologics > Live BiotherapeuticNatural product/Extract > Microbial extract
Mechanisms of ActionBacteria replacementsGastrointestinal microbiome modulators
TargetsNot applicable
Therapy Area/IndicationsIrritable Bowel Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIrelandUnited Kingdom
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator Companies4d Pharma Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive Companies4d Pharma Plc
Active IndicationsN/A
Inactive IndicationsIrritable Bowel Syndrome

Other Information

ATC CodeN/A
Related LinksN/A